- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Thomas Marsland on Financial Toxicity
Thomas Marsland, MD, talks about financial toxicity and the effect it has on patients.
Thomas Marsland, MD, talks about financial toxicity and the effect it has on patients.
Transcript:
While new, innovative therapies are often being developed in cancer care, these treatments can be extremely expensive. How is financial toxicity affecting patients, and how can it be mitigated?
So, I think that is the biggest challenge we face. We have these great new therapies, but they come at a fairly significant cost. But I think, as one of the other speakers mentioned this morning, the cost of the drug is only one part of a spectrum of costs. You know, it’s the cost of the administration, the cost of managing the toxicities, the hospitalizations, the emergency room visits [etc]. So I think, if all you’re looking at is the cost of the drug, and that drug is ‘x’, versus a drug whose cost is less—but if you’re looking at it as a continuum or more of what they call an episode of care, it may be that although the drug costs more, when you look at the total spectrum of care over a period of time, it may be that the drug actually saves money when you look at other pieces of the thing. A couple of the medical directors from several of the big payer communities have made a point that clearly drug cost is a significant piece, but it’s not the largest piece; I mean end of life care, you know… so appropriate planning, using the drug at the right time and for the right patients I think is one way that we can help to manage that cost and allow patients to get the type of care that they need.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
AUA Session Highlights the General Urologist’s Role in Gender-Affirming Care
May 7th 2024During her session, Polina Reyblat, MD, Kaiser Permanente Los Angeles Medical Center, highlighted best practices urologists should incorporate to make transgender and gender-diverse patients comfortable during physical exams and avoid retraumatization.
Read More
